🇺🇸 FDA
Patent

US 12186330

Compositions for improving cell viability and methods of use thereof

granted A61KA61K31/192A61K31/575

Quick answer

US patent 12186330 (Compositions for improving cell viability and methods of use thereof) held by Amylyx Pharmaceuticals, Inc. expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amylyx Pharmaceuticals, Inc.
Grant date
Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/192, A61K31/575, A61P, A61P25/28